A Case of Thrombotic Thrombocytopenic Purpura associated with Clopidogrel in a Patient with Acute Cerebral Infarction.
10.3904/kjm.2014.87.5.615
- Author:
Jinhee PARK
1
;
Yeongbok LEE
;
Haneul PARK
;
Jiwon MIN
;
Yumi KO
;
Young Ok KIM
Author Information
1. Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Seoul, Korea. junpearl19@catholic.ac.kr
- Publication Type:Case Report
- Keywords:
Thrombotic thrombocytopenic purpura;
Clopidogrel
- MeSH:
Abdominal Pain;
Cerebral Infarction*;
Hemorrhage;
Humans;
Korea;
Nausea;
Purpura;
Purpura, Thrombotic Thrombocytopenic*;
Stents;
Stroke;
Thrombocytopenia;
Thrombosis;
Vomiting
- From:Korean Journal of Medicine
2014;87(5):615-618
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Clopidogrel is an antiplatelet agent prescribed widely to prevent stent thrombosis after coronary or peripheral vascular interventions and for stroke prophylaxis. The side effects of this drug include gastrointestinal symptoms, such as nausea, abdominal pain, vomiting, and bleeding. Thrombotic thrombocytopenia purpura (TTP) is a rare complication of this drug. Here, we report a case of clopidogrel-associated TTP in a patient with cerebral infarction. To our knowledge, it is first reported case of clopidogrel-associated TTP in Korea.
